• Investing
  • Stock
  • Economy
BigMoneyHall.com – Investing and Stock News
  • Editor’s Pick
  • Latest News
Latest News

House Dems vote against bill to permanently classify fentanyl as Schedule 1 controlled substance

by March 9, 2023
by March 9, 2023

Democrats on the House Energy and Commerce Committee on Wednesday voted against legislation that would permanently classify both fentanyl and fentanyl-related substances (FRS) as Schedule 1 drugs that carry the toughest penalties for trafficking and possession.

Republicans say the growing fentanyl problem in America means the U.S. should permanently treat those drugs as Schedule 1 substances in the hopes of boosting penalties and stopping their spread. In 2018, the Trump administration temporarily scheduled FRS as a Schedule 1 drug in light of the growing number of fentanyl-related deaths, and Congress has extended that temporary status a few times since then.

House Republicans argue that it’s time to permanently reclassify fentanyl and FRS, and they called up a bill to do so in the Energy and Commerce health subcommittee on Wednesday to stop what several Republicans called the poisoning of tens of thousands of American citizens.

The subcommittee approved the bill in a 17-10 vote in which every Democrat voted against it except for Rep. Angie Craig, D-Minn. Other Democrats rejected the bill after arguing that the change should be coupled with an end to mandatory minimum sentences for FRS charges.

Specifically, Democrats said FRS cases that don’t lead to death or serious bodily harm should not carry mandatory minimum sentences, and they broadly argued that Republicans need to treat the matter more like a health crisis and less like a criminal crisis.

‘Mandatory minimums should take into account whether the cases involve overdoses or serious bodily harm,’ said Rep. Anna Eshoo, D-Calif.

Another Democrat, Rep. Frank Pallone of New Jersey, said Democrats support the Biden administration’s plan to only apply mandatory minimum sentences for FRS unless an offense results in serious harm or death, and to let people sentenced to seek lower sentences if an FRS is later classified as a less-harmful drug.

‘Republicans have refused to work with us’ on those and other provisions, Pallone said.

Groups that normally support Democrats, such as the ACLU and Human Rights Watch, argued in 2021 that maintaining tough penalties related to fentanyl would ‘exacerbate pretrial detention, mass incarceration and racial disparities in the prison system, doubling down on a fear-based, enforcement-first response to a public health challenge.’

But law enforcement groups have called for tougher penalties — in 2021, the National Fraternal Order of Police called on the government to address the ‘growing illicit fentanyl overdose epidemic that has gripped this country.’

Republicans said Wednesday that the deaths of tens of thousands of people due to fentanyl mean Congress must take swift action to ensure tough penalties against fentanyl and FRS. The government attributed 106,000 fentanyl-related deaths in 2021, and Rep. Bob Latta, R-Ohio, one of the sponsors of the bill, said fentanyl and FRS have become ‘weapons of mass destruction’ that must be policed.

‘This should not be a political issue,’ Latta said. ‘It’s about addressing the largest poisoning of Americans in the history of our country and taking steps to end the scourge.’

Republicans also rejected the idea from Democrats that tough fentanyl penalties are creating unfair sentences. Rep. Dan Crenshaw, R-Texas, said the growing number of fentanyl deaths of Americans is ‘murder at this point,’ and Rep. Brett Guthrie, R-Ky., said that making fentanyl and FRS riskier to bring into the country will both reduce the deaths and lower the number of fentanyl sentences.

‘The point is you can’t die from ingesting something that was never created, nor can you be incarcerated for selling something that doesn’t exist,’ he said.

Rep. Morgan Griffith, R-Va., added that because there are tens of thousands of fentanyl analogues already in existence, it makes no sense for Congress to try to analyze each one and assess which ones might pose no harm to people. He also said the GOP meets one demand being made by Democrats, which is to make it easier for researchers to access FRS in order to study these drugs.

Pete Kasperowicz is a politics editor at Fox News Digital.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
DHS removed just 409 of 345,000 unaccompanied child migrants since FY 2021
next post
House Republicans planning to visit Jan. 6 defendants in DC jail

Related Posts

‘What is this, a test?’ Members of Congress...

June 1, 2023

Trump’s call to end birthright citizenship echoes past...

June 1, 2023

Activists launch Jews Against Soros to oppose mega-donor’s...

June 1, 2023

Senate GOP demands answers on security clearances of...

June 1, 2023

Nevada’s GOP governor signs law enhancing penalties for...

June 1, 2023

Trump-backed Majewski drops second bid to unseat longstanding...

June 1, 2023

DeSantis response to Trump attack sparks laughs from...

June 1, 2023

California lawmakers to honor anti-Catholic Sisters of Perpetual...

June 1, 2023

Pence calls Los Angeles Dodgers’ decision to honor...

June 1, 2023

Utah Rep Chris Stewart to resign from House,...

May 31, 2023
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • ‘What is this, a test?’ Members of Congress reveal whether they read the debt ceiling bill

    June 1, 2023
  • Trump’s call to end birthright citizenship echoes past calls, likely to face similar opposition

    June 1, 2023
  • Activists launch Jews Against Soros to oppose mega-donor’s ‘radical left-wing influence’

    June 1, 2023
  • Senate GOP demands answers on security clearances of signatories of Hunter Biden laptop letter

    June 1, 2023
  • Nevada’s GOP governor signs law enhancing penalties for election worker intimidation

    June 1, 2023
  • Trump-backed Majewski drops second bid to unseat longstanding House Democrat

    June 1, 2023

Editors’ Picks

  • 1

    Heads Up: Bulls Get Benefit of the Doubt as Positive Breadth Divergence Emerges

    January 23, 2023
  • 2

    Pentagon says US detected third flying ‘object’ over Alaska a day before shooting down over Canada

    February 12, 2023
  • 3

    Deutsche Telekom and T‑Mobile US introduce Network APIs and a Joint Developer Platform in Germany and the US

    February 27, 2023
  • 4

    Importance of Data Masking Techniques in IoT Landscape: 2023 and Beyond

    January 23, 2023
  • 5

    Democrat leadership leaves Adam Schiff hanging on call for intelligence assessment of Biden’s classified docs

    January 16, 2023
  • 6

    US possibly scammed out of tens of millions by Wuhan Lab: reports

    March 14, 2023
  • 7

    Noem blocks South Dakota business with certain companies owned or controlled by ‘evil foreign governments’

    January 20, 2023

Categories

  • Economy (13)
  • Editor's Pick (156)
  • Investing (71)
  • Latest News (1,546)
  • Stock (512)

Latest News

  • Inflation’s Cooling, But Stock Market Isn’t Celebrating: What Gives?

    May 11, 2023
  • Minnesota officials stump for legislative crackdown on ‘forever chemicals’

    March 24, 2023
  • Biden makes multiple false Second Amendment claims in wake of Nashville Covenant School tragedy

    March 29, 2023

Investing News

  • Natural Gas and Oil — Always on the Radar

    May 18, 2023
  • Biden flirts with crossing ethical lines in talking about DOJ’s Hunter investigation, experts say

    May 10, 2023
  • Technical and Fundamental Analysis on US Oil Fund

    May 15, 2023
  • About Us
  • Contacts
  • Email Whitelisting
  • Privacy Policy
  • Terms and Conditions

Disclaimer: BigMoneyHall.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023 BigMoneyHall.com. All Rights Reserved.

BigMoneyHall.com – Investing and Stock News
  • Investing
  • Stock
  • Economy
BigMoneyHall.com – Investing and Stock News
  • Editor’s Pick
  • Latest News
BigMoneyHall.com – Investing and Stock News
  • Investing
  • Stock
  • Economy
BigMoneyHall.com – Investing and Stock News
  • Editor’s Pick
  • Latest News

Disclaimer: BigMoneyHall.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023 BigMoneyHall.com. All Rights Reserved.

Read alsox

North Dakota House passes trans bathroom, sexually...

April 22, 2023

House GOP grill 25 Biden admin agencies...

May 19, 2023

Georgia Senate passes bill to discipline prosecutors...

March 3, 2023